SEATTLE, WA / ACCESS Newswire / March 19, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary A ...
Part of ZenaDrone's Counter-UAS defense system being built for modern asymmetric warfare for U.S. Defense and allied forcesVANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results